<DOC>
	<DOCNO>NCT03081650</DOCNO>
	<brief_summary>The primary purpose study show whether home usage AIRVO warm humidifier potentially reduce number exacerbation patient significant respiratory insufficiency . Eligible participant study must diagnosis chronic obstructive pulmonary disease ( COPD ) stage II-IV..</brief_summary>
	<brief_title>The Efficacy AIRVO Warm Humidifier Add Oxygen Therapy</brief_title>
	<detailed_description>SPECIFIC AIMS/OBJECTIVES To determine whether patient chronic respiratory sufficiency benefit AIRVO warm humidifier decrease number exacerbation . Furthermore , determine efficacy warm humidification oxygen therapy compare dry oxygen therapy , short-term long-term treatment patient stage II-IV COPD . Primary Objective : To observer compare exacerbation frequency warm humidification oxygen therapy group dry oxygen therapy group . Secondary Objective : Compare number exacerbation day , median time first exacerbation , hospital readmission , antibiotic use pertain respiratory infection baseline value . Evaluate compare quality life baseline measurement . STUDY OVERVIEW Methods : The study conduct open label , non-randomized trial . Patients assign AIRVO humidification meet inclusion/exclusion criterion study . All study participant AIRVO warm humidifier instal home stand alone unit addition current LTOT therapy . For patient already LTOT , oxygen flow set increase 20-25 l/min , optimum flow take consideration patient 's preference . Data : Data collect include exacerbation frequency , number exacerbation day , time first exacerbation , pulmonary function test , antibiotic usage Quality Life assessment . Description AIRVO : The AIRVO treatment spontaneously breathe patient would benefit receive high flow warm humidified respiratory gas . The AIRVO humidifier adjustable flow set delivery fully saturate breathe gas 37°C , 100 % humidity . Flow rate humidifier adjustable 10 60 L/min specific population ( general 2 -60 L/min ) . AIRVO humidifier intend use combination medical oxygen supply . When coupled medical oxygen supply , regulation oxygen concentration ensure , allow treatment COPD patient great oxygen flow without risk increased accumulation carbon dioxide . The mixed gas , atmospheric air medical oxygen , pas humidification chamber sterile water humidification heating . Breathing tube equip spiral wire , aid heat ensures uniform temperature humidity maintain . The air supply patient 37°C , 100 % humidity . [ 16 ] Treatment group : ARIVO : All patient Selected participate study give AIRVO humidifier study sponsor . Patients connect instructed use AIRVO . The total flow set 20-25 L/min , exact flow rate dependent patient 's preference . Optiflow oxygen catheter use ensure unpleasant sensation due high flow avoid push back system . When acceptable flow rate establish , record patient 's folder . The patient instruct use AIRVO minimum eight ( 8 ) hour period , preferably night . Using humidifier long period time allow . The total number hour humidifier operational recorded end study .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>Have stage IIIV COPD diagnosis Understand accept oral write information English Be capable handle AIRVO warm humidifier instruction &gt; 18years age Comorbidity ( know malignant disease , terminal illness , dementia , uncontrolled mental illness ) Bronchiectasis without simultaneous COPD diagnosis Treatment BiPAP home Affected level consciousness Smoking status change study period Inability provide sign consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>